Literature DB >> 11480581

Familial polycythemia vera: results from the Swedish Family-Cancer Database.

K Hemminki, Y Jiang.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11480581     DOI： 10.1038/sj.leu.2402177

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2018-07-10       Impact factor: 22.113

2.  Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa Women's Health Study cohort.

Authors:  Alexis D Leal; Carrie A Thompson; Alice H Wang; Robert A Vierkant; Thomas M Habermann; Julie A Ross; Ruben A Mesa; Beth A Virnig; James R Cerhan
Journal:  Int J Cancer       Date:  2013-10-15       Impact factor: 7.396

Review 3.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

4.  Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera.

Authors:  Elina A M Hirvonen; Esa Pitkänen; Kari Hemminki; Lauri A Aaltonen; Outi Kilpivaara
Journal:  Hum Genomics       Date:  2017-04-20       Impact factor: 4.639

5.  Lifestyle factors and risk of myeloproliferative neoplasms in the NIH-AARP diet and health study.

Authors:  Nikolai A Podoltsev; Xiaoyi Wang; Rong Wang; Jonathan N Hofmann; Linda M Liao; Amer M Zeidan; Ruben Mesa; Xiaomei Ma
Journal:  Int J Cancer       Date:  2020-01-29       Impact factor: 7.396

6.  Diet and Risk of Myeloproliferative Neoplasms in Older Individuals from the NIH-AARP Cohort.

Authors:  Nikolai A Podoltsev; Xiaoyi Wang; Rong Wang; Jonathan N Hofmann; Linda M Liao; Amer M Zeidan; Ruben A Mesa; Xiaomei Ma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-08-31       Impact factor: 4.254
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.